Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Roche spins out BioXell; spin-off raises $19.3mm in Series A financing

Executive Summary

The Italian division of Roche has spun off a biotech immunology company called BioXell, in which it will retain a 17% ownership. In its Series A financing, BioXell brought in $19.3mm (Euro22mm).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Spin-Off

Related Companies

Advertisement
UsernamePublicRestriction

Register